Effect of older age at initiation of antiretroviral therapy on patient retention in an urban ART program in Uganda

Neurobehavioral HIV Medicine

Volumn 3, Issue 1, 2011, Pages 1-8

  Nakimuli Mpungu, Etheldreda ^a,b   Nakasujja, Noeline ^b   Akena, Howard Dickens ^b   Kiwuwa, Steven Mpungu ^b   Katabira, Elly ^c   Okello, Elilialia ^b   Onyike, Chiadi ^d   Musisi, Seggane ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Epidemiology and Molecular Microbiology Immunology   (Uganda)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acquired immune deficiency syndrome; Antiretroviral therapy; Human immunodeficiency virus; Neuropsychiatric syndromes; Old age; Uganda

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH PROGRAM; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; PERIPHERAL NEUROPATHY; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL; TOXOPLASMOSIS; UGANDA; URBAN AREA; WASTING SYNDROME;

EID: 79960984047     PISSN: None     EISSN: 11791497     Source Type: Journal    
DOI: 10.2147/NBHIV.S13276     Document Type: Article

References (39)

1. Amolo-Okero F, Aceng E, Madraa M, Namagala E. Scaling up antiretroviral therapy: Experience in Uganda case study. Available at: http:// www.who.int/hiv/amds/case3.pdf. Accessed 2010 Nov 16.
2. The National Strategic Framework for Expansion of HIV/AIDS Care and Support in Uganda, 2001/2-2005/6. Kampala; Ministry of Health: 2002 Feb. Available at: http://www.aidsuganda.org/mtr/Annex_2_TWG_2_Report.pdf. Accessed 2010 Nov 16.
3. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197: S272-S278.
4. Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of classspecific antiretroviral resistance. AIDS. 2009;23:1035-1046.
5. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. PLoS Med. 2007;4:e298.
6. Uganda Ministryof Health (2006) 2004-05 Uganda HIV/AIDS serobehavioural survey. Available at: http://www.measuredhs.com/pubs/ pdf/AIS2/AIS2.pdf. Accessed 2010 Nov 16.
7. The Swaziland Demographic and Health Survey (2006-2007). Available at: http://www.safaids.net/files/Swaziland%20Demographic%20and%20Health%20Survey%202006-2007.pdf. Accessed 2010 Nov 16.
8. Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18:S11-S18.
9. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol. 2001;54:S44-S52.
10. Nakasujja N, Musisi S, Byakika-Kibwika P, Katabira E. HIV/AIDS among the elderly: A sociodemographic survey at the Mildmay Clinic Kampala, Uganda. Proceedings of the 4th Annual Makerere University College of Health Sciences Scientific Conference. Kampala, Uganda, 2008 Sep 17-19.
11. Stoff DM. Mental health research in HIV/AIDS and aging: Problems and prospects. AIDS. 2004;18:S3-S10.
12. Kooperman L. A survey of gay and bisexual men age 50 and older. AIDS related knowledge, attitude, belief, and behavior. AIDS Patient Care. 1994;8:114-117.
13. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. The national AIDS behavioral surveys. Arch Intern Med. 1994;154:57-63.
14. Zablotsky D, Kennedy M. Risk factors and HIV transmission to midlife and older women: Knowledge, options, and the initiation of safer sexual practices. J Acquir Immune Defic Syndr. 2003;33:S122-S130.
15. Justice AC, McGinnis KA, Atkinson JH, et al; Veterans Aging Cohort 5-Site Study Project Team. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans aging cohort five-site study. AIDS. 2004;18:S49-S59.
16. Ibara JR, Itoua C, Gathse A, et al. Acquired immunodeficiency syndrome in elderly persons in a tropical zone. Apropos of 175 cases in the Congo. Bull Soc Pathol Exot. 2002;95:100-102.
17. Biggar RJ, Kirby KA, Atkinson J, McNeel TS, Engels E; AIDS Cancer Match Study Group. Cancer risk in elderly persons with HIV/AIDS. J Acquir Immune Defic Syndr. 2004;36:861-868.
18. Heckman TG, Heckman BD, Kochman A, Sikkema KJ, Suhr J, Goodkin K. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment Health. 2002;6:121-128.
19. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York, NY: Springer-Verlag; 1992.
20. Zingmond DS, Kilbourne AM, Justice AC, et al. Differences in symptom expression in older HIV-positive patients: The veterans aging cohort 3 site study and HIV cost and service utilization study experience. J Acquir Immune Defic Syndr. 2003;33:S84-S92.
21. Cohen CR, Montandon M, Carrico AW, et al. Association of attitudes and beliefs towards antiretroviral therapy with HIV-seroprevalence in the general population of Kisumu, Kenya. PLoS One. 2009;4:e4573.
22. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: The Hawaii aging with HIV-1 cohort. Neurology. 2004;63:822-827.
23. Baldeweg T, Catalan J, Gazzard BG. Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy. J Neurol Neurosurg Psychiatry. 1998;65:34-41.
24. Goodkin K, Wilkie FL, Concha M, et al. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol. 2001;54:S35-S43.
25. Akena DH, Musisi S, Kinyanda E. A comparison of the clinical features of depression in HIV-positive and HIV-negative patients in Uganda. Afr J Psychiatry (Johannesbg). 2010;13:43-51.
26. Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E. Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry. 2006;163:1349-1354.
27. Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S, Katabira E. Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics. 2008;49:530-534.
28. Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E. Clinical presentation of bipolar mania in HIV-positive patients in Uganda. Psychosomatics. 2009;50:325-330.
29. Kallman DA, Plato CC, Tobin JD. The role of muscle loss in the age-related decline of grip strength: Cross-sectional and longitudinal perspectives. J Gerontol. 1990;45:M82-M88.
30. Koethe JR, Heimburger DC. Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr. 2010;91: S1138-S1142.
31. Operskalski EA, Mosley JW, Busch MP, Stram DO. Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion safety study group. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:243-244.
32. Soriano V, Castilla J, Gomez-Cano M, et al. The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load. J Infect. 1998;36:307-311.
33. Adler WH, Baskar PV, Chrest FJ, Dorsey-Cooper B, Winchurch RA, Nagel JE. HIV infection and aging: Mechanisms to explain the accelerated rate of progression in the older patient. Mech Ageing Dev. 1997;96:137-155.
34. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIVinfected adults: Effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19-S25.
35. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa. J Acquir Immune Defic Syndr. 2009;51:65-71.
36. Knol MJ, Janssen KJ, Donders AR, et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: An empirical example. J Clin Epidemiol. 2010;63:728-736.
37. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children convened by the National Pediatric and Family HIV Resource Center (NPHRC), the Health Resources and Services Administration (HRSA), and the National Institute of Health (NIH). Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR. 2000:1-59.
38. Carpenter CCJ, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283:381-390.
39. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992;42:1472-1476.